A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401

Author： Oh In-Jae   Kim Kyu-Sik   Kim Young-Chul   Ban Hee-Jung   Kwon Yong-Soo   Kim Yu-Il   Lim Sung-Chul   Chung Woong-Ki   Nam Taek-Keun   Song Joo-Young   Yoon Mee-Sun   Ahn Sung-Ja  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.6, 2013-12, pp. : 1247-1254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Stage III Unresectable Non-small Cell Lung Cancer

By Tan Eng H.   Wee Joseph   Ang Peng T.   Fong Kam W.   Leong Swan S.   Khoo Kei S.   Tan Terence   Lee Kim S.   Eng Philip   Hsu Anne   Tan Yoke K.   Chua E. J.   Ong Yong Y.  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1005-1009

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

By Solomon B.   Ball D.L.   Richardson G.   Smith J.G.   Millward M.   MacManus M.   Michael M.   Wirth A.   O'Kane C.   Muceniekas L.   Ryan G.   Rischin D.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

By Zatloukal P.   Petruzelka L.   Zemanova M.   Kolek V.   Skrickova J.   Pesek M.   Fojtu H.   Grygarkova I.   Sixtova D.   Roubec J.   Horenkova E.   Havel L.   Prusa P.   Novakova L.   Skacel T.V.   Kuta M.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 321-331

Elsevier

Access to resources Recommend Favorite

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401

By Takayama Koichi   Inoue Koji   Tokunaga Shoji   Matsumoto Takemasa   Oshima Tsukasa   Kawasaki Masayuki   Imanaga Tomotoshi   Kuba Mutsuo   Takeshita Masafumi   Harada Taishi   Shioyama Yoshiyuki   Nakanishi Yoichi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1353-1359

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

By Kroep J.   Smit E.   Giaccone G.   Born K.   Beijnen J.   Groeningen C.   Vijgh W.   Postmus P.   Pinedo H.   Peters G.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 509-516

Springer Publishing Company

Access to resources Recommend Favorite